The Predictive Value of Albumin-to-Creatinine Ratio on Mortality and Its Mediation in Metabolic Dysfunction-Associated Steatotic Liver Disease Among U.S. Adults: Insights from NHANES 1999–2018 - Scorecard - MDSpire

The Predictive Value of Albumin-to-Creatinine Ratio on Mortality and Its Mediation in Metabolic Dysfunction-Associated Steatotic Liver Disease Among U.S. Adults: Insights from NHANES 1999–2018

  • By

  • Huanjie Zhou

  • Hao Huang

  • Huiliu Zhao

  • Naiqi Pang

  • Meifang Huang

  • Chao Ou

  • Ming Lao

  • November 19, 2025

  • 0 min

Share

Clinical Scorecard: The Predictive Value of Albumin-to-Creatinine Ratio on Mortality and Its Mediation in Metabolic Dysfunction-Associated Steatotic Liver Disease Among U.S. Adults: Insights from NHANES 1999–2018

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationU.S. adults with MASLD as defined by hepatic steatosis and metabolic dysfunction, including specific criteria.
Care Setting

Key Highlights

  • highlight_5

Guideline-Based Recommendations

Diagnosis

  • Use ACR to assess microalbuminuria in patients with MASLD, referencing relevant guidelines.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Include pharmacological options for managing metabolic dysfunction.

        Clinical Best Practices

        • best_practice_2

        References

        Original Source(s)

        The Predictive Value of Albumin-to-Creatinine Ratio on Mortality and Its Mediation in Metabolic Dysfunction-Associated Steatotic Liver Disease Among U.S. Adults: Insights from NHANES 1999–2018

        • by Huanjie Zhou, Hao Huang, Huiliu Zhao, Naiqi Pang, Meifang Huang, Chao Ou, Ming Lao

        • November 19, 2025

        Related Content

        Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

        Laparoscopic Roux-en-Y Gastric Bypass with the Maestro™ System: a Novel Collaborative Robotic Platform

        Safety Framework for Gastric Mucosal Ablation (GMA) Using Hybrid Argon Plasma Coagulation (hAPC): International Expert Consensus